A notable advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://finnianvres048918.buscawiki.com/2289599/revolutionary_introduction_tirzepatide_45mg_for_blood_sugar_regulation